Digital PCR (dPCR), the third generation of PCR technology, enables absolute quantification of nucleic acids by partitioning samples into thousands of individual reactions.
This article provides a comprehensive analysis of liquid and tissue biopsy for researchers and drug development professionals.
This article provides a comprehensive exploration of circulating tumor DNA (ctDNA), covering its fundamental biology and the mechanisms by which it is released into the circulation.
This article provides a comprehensive overview of circulating tumor DNA (ctDNA), a cornerstone of liquid biopsy in precision oncology.
Cancer stem cells (CSCs) are a pivotal subpopulation driving tumor initiation, progression, and relapse due to their self-renewal capacity, differentiation potential, and profound resistance to conventional therapies.
This article provides a comprehensive roadmap for researchers and drug development professionals on the validation of predictive biomarkers for cancer immunotherapy.
This article provides a comprehensive overview of the latest research on the tumor microenvironment (TME) and its profound influence on cancer cell behavior, progression, and therapeutic response.
This article provides a comprehensive analysis of the comparative performance of various PD-L1 immunohistochemistry (IHC) assays, a critical predictive biomarker for immune checkpoint inhibitor response.
This article addresses the critical challenge of validating cancer risk prediction models across racially, ethnically, and geographically diverse populations—a prerequisite for equitable clinical application.
This comprehensive review systematically compares established and emerging molecular techniques for cancer diagnostics, addressing the needs of researchers, scientists, and drug development professionals.